Table 1.

Baseline demographic and clinical characteristics

Characteristics	Placebo (n = 14)	um-PEA (n = 15)
Female, n (%)	9 (64)	6 (40)
Age (years)	28.93 ± 4.86	30.60 ± 7.60
EDSS score	2.3 ± 0.97	1.7 ± 0.9
VAS	58.5 ± 11.4	63.6 ± 18.7
Erythema (Ø)	23.1 ± 24.6	27.1 ± 22.7
MSQoL cognitive function	74.2 ± 9.6	71.4 ± 21.8
MSQoL change in health	42.0 ± 25.3	50.0 ± 16.9

Data are expressed as mean ± SD unless otherwise indicated

um-PEA = Ultramicronized palmitoylethanolamide; EDSS = Expanded Disability Status Scale; VAS = Visual Analog Scale; MSQoL = Multiple Sclerosis Quality of Life-54